Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Abraxis BioScience

Biotech & Life Sciences · Los Angeles, United States · Founded 2007 Unicorn

Therapeutics and core technologies for the treatment of cancer and other critical illnesses

Headcount
100–500
Current team size
Unlock exact value

Global footprint

Where Abraxis BioScience has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States91.2%
🇲🇽 Mexico2.9%
🇨🇦 Canada2.9%
🇮🇹 Italy2.9%
4 countries shown

Patent intelligence

$169M patent portfolio · 60 active families

Estimated portfolio value
$169M
comparable to top peer Ganymed Pharmaceuticals ($223M)
60 active patent families
Where Abraxis BioScience innovates DiseaseNanoparticleAlbuminCancer researchOncology

Where Abraxis BioScience concentrates vs peers

Each axis is a top-10 topic across Abraxis BioScience and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Abraxis BioScience

An AI-synthesized read of the highest-engagement posts about Abraxis BioScience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Abraxis BioScience on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.